283 related articles for article (PubMed ID: 22370746)
21. Aspects related to biofilm production and antifungal susceptibility of clinically relevant yeasts of the genus Trichosporon.
Lara BR; de Camargo BB; Paula CR; Monari GPM; Garces HG; Arnoni MV; Silveira M; Gimenes VMF; Leite Junior DP; Bonfietti LX; Oliveira L; Melhem MSC; Auler M; Ramos RTB; Dias ALT; Silva NC; Moreira D; Richini-Pereira VB; Anversa L; Ruiz LDS
Med Mycol; 2023 Mar; 61(3):. PubMed ID: 36807459
[TBL] [Abstract][Full Text] [Related]
22. Molecular and antifungal susceptibility study on trichosporonemia and emergence of Trichosporon mycotoxinivorans as a bloodstream pathogen.
Dabas Y; Xess I; Kale P
Med Mycol; 2017 Jul; 55(5):518-527. PubMed ID: 27816903
[TBL] [Abstract][Full Text] [Related]
23. Trichosporon asahii infection presenting as chronic meningo-ventriculitis and intra ventricular fungal ball: a case report and literature review.
Kumar A; Udayakumaran S; Babu R; Rajamma BM; Prakash A; Panikar D; Karim S; Chowdhary A
Mycoses; 2015 Feb; 58(2):99-103. PubMed ID: 25590228
[TBL] [Abstract][Full Text] [Related]
24. [Nosocomial urinary infection due to Trichosporon asahii. First two cases in Chile].
Silva V; Zepeda G; Alvareda D
Rev Iberoam Micol; 2003 Mar; 20(1):21-3. PubMed ID: 12825977
[TBL] [Abstract][Full Text] [Related]
25. Mixed Infection of Toe Nail Caused by Trichosporon asahii and Rhodotorula mucilaginosa.
Idris NFB; Huang G; Jia Q; Yuan L; Li Y; Tu Z
Mycopathologia; 2020 Apr; 185(2):373-376. PubMed ID: 31760556
[TBL] [Abstract][Full Text] [Related]
26. Genotyping, extracellular compounds, and antifungal susceptibility testing of Trichosporon asahii isolated from Mexican patients.
Montoya AM; Sánchez González A; Palma-Nicolás JP; Gómez-Treviño A; González JG; González GM
Med Mycol; 2015 Jun; 53(5):505-11. PubMed ID: 25980003
[TBL] [Abstract][Full Text] [Related]
27. [Antifungal susceptibility and drug-resistant mechanism of Trichosporon].
Kushima H; Tokimatsu I; Ishii H; Kadota J
Med Mycol J; 2015; 56(4):J123-8. PubMed ID: 26617108
[TBL] [Abstract][Full Text] [Related]
28. Invasive trichosporonosis caused by Trichosporon asahii and other unusual Trichosporon species at a medical center in Taiwan.
Ruan SY; Chien JY; Hsueh PR
Clin Infect Dis; 2009 Jul; 49(1):e11-7. PubMed ID: 19489711
[TBL] [Abstract][Full Text] [Related]
29. Successful Treatment of Breakthrough Trichosporon asahii Fungemia by the Combination Therapy of Fluconazole and Liposomal Amphotericin B in a Patient with Follicular Lymphoma.
Itoh K; Iwasaki H; Negoro E; Shigemi H; Tokimatsu I; Tsutani H; Yamauchi T
Mycopathologia; 2021 Mar; 186(1):113-117. PubMed ID: 33389484
[TBL] [Abstract][Full Text] [Related]
30. In vitro combined activity of amphotericin B, caspofungin and voriconazole against clinical isolates of Trichosporon asahii.
Li H; Lu Q; Wan Z; Zhang J
Int J Antimicrob Agents; 2010 Jun; 35(6):550-2. PubMed ID: 20202797
[TBL] [Abstract][Full Text] [Related]
31. Genotype, antifungal susceptibility, and biofilm formation of Trichosporon asahii isolated from the urine of hospitalized patients.
Almeida AA; Crispim Bdo A; Grisolia AB; Svidzinski TI; Ortolani LG; Oliveira KM
Rev Argent Microbiol; 2016; 48(1):62-6. PubMed ID: 26916812
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the microdilution, Etest and disk diffusion methods for antifungal susceptibility testing of clinical strains of Trichosporon spp.
Metin DY; Hilmioglu-Polat S; Hakim F; Inci R; Tumbay E
J Chemother; 2005 Aug; 17(4):404-8. PubMed ID: 16167520
[TBL] [Abstract][Full Text] [Related]
33. Trichosporon inkin meningitis in Northeast Brazil: first case report and review of the literature.
Milan EP; Silva-Rocha WP; de Almeida JJS; Fernandes TUG; de Araújo Prudente AL; de Azevedo MF; Francisco EC; de Azevedo Melo AS; Colombo AL; Chaves GM
BMC Infect Dis; 2018 Sep; 18(1):470. PubMed ID: 30227852
[TBL] [Abstract][Full Text] [Related]
34. A rare case of urinary tract infection due to Trichosporon asahii in a diabetic patient.
Iken M; Belkouch A; Bellarj B; Naoui H; Boumhil L; El Bouti A; Jidane S; Belyamani L; Lmimouni B
Pan Afr Med J; 2015; 20():127. PubMed ID: 26097631
[TBL] [Abstract][Full Text] [Related]
35. Emerging Trichosporon asahii in elderly patients: epidemiological and molecular analysis by the DiversiLab system.
Treviño M; García-Riestra C; Areses P; García X; Navarro D; Suárez FJ; López-Dequidt IA; Zaragoza O; Cuenca-Estrella M
Eur J Clin Microbiol Infect Dis; 2014 Sep; 33(9):1497-503. PubMed ID: 24718613
[TBL] [Abstract][Full Text] [Related]
36. [Nosocomial infection due to Trichosporon asahii in a critical burned patient].
Tamayo Lomas L; Domínguez-Gil González M; Martín Luengo AI; Eiros Bouza JM; Piqueras Pérez JM
Rev Iberoam Micol; 2015; 32(4):257-60. PubMed ID: 25579090
[TBL] [Abstract][Full Text] [Related]
37. In Vitro Antifungal Activity of Sertraline and Synergistic Effects in Combination with Antifungal Drugs against Planktonic Forms and Biofilms of Clinical Trichosporon asahii Isolates.
Cong L; Liao Y; Yang S; Yang R
PLoS One; 2016; 11(12):e0167903. PubMed ID: 27930704
[TBL] [Abstract][Full Text] [Related]
38. Implication of efflux pumps and
Abbes S; Sellami H; Neji S; Trabelsi H; Makni F; Ayadi A
J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33688802
[No Abstract] [Full Text] [Related]
39. Antifungal pharmacodynamic characteristics of amphotericin B against Trichosporon asahii, using time-kill methodology.
Toriumi Y; Sugita T; Nakajima M; Matsushima T; Shinoda T
Microbiol Immunol; 2002; 46(2):89-93. PubMed ID: 11939583
[TBL] [Abstract][Full Text] [Related]
40. Invasive Infections Due to
Guo LN; Yu SY; Hsueh PR; Al-Hatmi AMS; Meis JF; Hagen F; Xiao M; Wang H; Barresi C; Zhou ML; de Hoog GS; Xu YC
J Clin Microbiol; 2019 Feb; 57(2):. PubMed ID: 30463892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
